25 XP   0   0   10

Boai NKY Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Boai NKY Pharmaceuticals Ltd together

PenkeI guess you are interested in Boai NKY Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Boai NKY Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Boai NKY Pharmaceuticals Ltd

I send you an email if I find something interesting about Boai NKY Pharmaceuticals Ltd.

Quick analysis of Boai NKY Pharmaceuticals Ltd (30 sec.)










What can you expect buying and holding a share of Boai NKY Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.07
When do you have the money?
1 year
How often do you get paid?
97.4%

What is your share worth?

Current worth
¥10.65
Expected worth in 1 year
¥11.66
How sure are you?
84.6%

+ What do you gain per year?

Total Gains per Share
¥1.52
Return On Investment
8.1%

For what price can you sell your share?

Current Price per Share
¥18.65
Expected price per share
¥16.80 - ¥20.53
How sure are you?
50%

1. Valuation of Boai NKY Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)

¥18.65

Intrinsic Value Per Share

¥-6.61 - ¥6.97

Total Value Per Share

¥4.04 - ¥17.62

2. Growth of Boai NKY Pharmaceuticals Ltd (5 min.)




Is Boai NKY Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$475.4m$458.1m-$7.3m-1.6%

How much money is Boai NKY Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$14.4m$16.2m-$1.7m-12.4%
Net Profit Margin26.1%31.3%--

How much money comes from the company's main activities?

3. Financial Health of Boai NKY Pharmaceuticals Ltd (5 min.)




What can you expect buying and holding a share of Boai NKY Pharmaceuticals Ltd? (5 min.)

Welcome investor! Boai NKY Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Boai NKY Pharmaceuticals Ltd.

What can you expect buying and holding a share of Boai NKY Pharmaceuticals Ltd?

First you should know what it really means to hold a share of Boai NKY Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Boai NKY Pharmaceuticals Ltd is ¥18.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Boai NKY Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Boai NKY Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.65. Based on the TTM, the Book Value Change Per Share is ¥0.25 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.13 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Boai NKY Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.060.3%0.040.2%0.050.3%0.030.1%0.020.1%
Usd Book Value Change Per Share0.090.5%0.030.2%0.010.1%0.050.3%0.030.2%
Usd Dividend Per Share0.000.0%0.020.1%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.090.5%0.050.3%0.010.1%0.060.3%0.040.2%
Usd Price Per Share2.77-3.23-2.85-2.55-4.22-
Price to Earnings Ratio11.31-45.65-20.87-41.51-129.42-
Price-to-Total Gains Ratio31.22--523.19-1.32--67.55-253.79-
Price to Book Ratio1.88-2.33-2.14-2.06-9.30-
Price-to-Total Gains Ratio31.22--523.19-1.32--67.55-253.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.58116
Number of shares387
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.030.05
Usd Total Gains Per Share0.050.06
Gains per Quarter (387 shares)20.3421.83
Gains per Year (387 shares)81.3687.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1275471127677
25410815223152164
38216323335227251
410921731446303338
513627139558379425
616332547669455512
719037955781531599
821843363892606686
9245488719104682773
10272542800115758860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%18.01.00.094.7%38.01.00.097.4%53.01.00.098.1%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%14.05.00.073.7%33.06.00.084.6%46.08.00.085.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%38.00.01.097.4%52.00.02.096.3%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%14.05.00.073.7%33.06.00.084.6%48.06.00.088.9%

Fundamentals of Boai NKY Pharmaceuticals Ltd

About Boai NKY Pharmaceuticals Ltd

Boai NKY Medical Holdings Ltd. engages in the fine chemical and medical care businesses in China and internationally. The company offers polyvinylpyrrolidone (PVP) series products, and vinyl methyl ether and maleic acid products; anhydride copolymer (PVME/MA) series products; GBL, 2-pyrrolidone, NVP monomer, PVPK series (povidone), copovidone, and other VP/VA copolymer series products; and PVPP (cross-linked povidone), PVP-I, and related pharmaceutical intermediates. Its products are used in chemical, pharmaceutical, brewing and beverage, pigment and coating, textile, paper, oil extraction, photosensitive material, and electronic industries. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to Boai NKY Medical Holdings Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Jiaozuo, China.

Fundamental data was last updated by Penke on 2024-03-25 22:01:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Boai NKY Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Boai NKY Pharmaceuticals Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 33.4% means that ¥0.33 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 33.4%. The company is making a huge profit. +2
  • The TTM is 26.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.4%TTM26.1%+7.3%
TTM26.1%YOY31.3%-5.2%
TTM26.1%5Y18.0%+8.1%
5Y18.0%10Y17.6%+0.5%
1.1.2. Return on Assets

Shows how efficient Boai NKY Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • 3.6% Return on Assets means that Boai NKY Pharmaceuticals Ltd generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 3.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.6%TTM2.7%+0.9%
TTM2.7%YOY3.0%-0.3%
TTM2.7%5Y1.6%+1.2%
5Y1.6%10Y1.6%+0.0%
1.1.3. Return on Equity

Shows how efficient Boai NKY Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • 4.1% Return on Equity means Boai NKY Pharmaceuticals Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM3.2%+1.0%
TTM3.2%YOY3.5%-0.4%
TTM3.2%5Y1.9%+1.2%
5Y1.9%10Y1.9%+0.0%

1.2. Operating Efficiency of Boai NKY Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Boai NKY Pharmaceuticals Ltd is operating .

  • Measures how much profit Boai NKY Pharmaceuticals Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM26.6%-26.6%
TTM26.6%YOY22.1%+4.5%
TTM26.6%5Y20.7%+5.9%
5Y20.7%10Y10.1%+10.6%
1.2.2. Operating Ratio

Measures how efficient Boai NKY Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ¥0.93 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 0.931. The company is less efficient in keeping operating costs low.
  • The TTM is 1.092. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.931TTM1.092-0.161
TTM1.092YOY1.320-0.228
TTM1.0925Y1.285-0.193
5Y1.28510Y0.899+0.386

1.3. Liquidity of Boai NKY Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Boai NKY Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.84 means the company has ¥2.84 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 2.838. The company is able to pay all its short-term debts. +1
  • The TTM is 2.876. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.838TTM2.876-0.039
TTM2.876YOY4.182-1.305
TTM2.8765Y2.109+0.768
5Y2.10910Y1.027+1.081
1.3.2. Quick Ratio

Measures if Boai NKY Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 1.02 means the company can pay off ¥1.02 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 1.022. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.150. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.022TTM1.150-0.128
TTM1.150YOY1.866-0.716
TTM1.1505Y0.925+0.225
5Y0.92510Y0.837+0.088

1.4. Solvency of Boai NKY Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Boai NKY Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.13 means that Boai NKY Pharmaceuticals Ltd assets are financed with 13.5% credit (debt) and the remaining percentage (100% - 13.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 0.135. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.144. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.135TTM0.144-0.009
TTM0.144YOY0.137+0.007
TTM0.1445Y0.221-0.077
5Y0.22110Y0.196+0.025
1.4.2. Debt to Equity Ratio

Measures if Boai NKY Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 15.5% means that company has ¥0.15 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The MRQ is 0.155. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.167. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.155TTM0.167-0.012
TTM0.167YOY0.159+0.009
TTM0.1675Y0.299-0.132
5Y0.29910Y0.266+0.033

2. Market Valuation of Boai NKY Pharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Boai NKY Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Boai NKY Pharmaceuticals Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 11.31 means the investor is paying ¥11.31 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The EOD is 10.540. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.314. Based on the earnings, the company is underpriced. +1
  • The TTM is 45.648. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.540MRQ11.314-0.774
MRQ11.314TTM45.648-34.335
TTM45.648YOY20.869+24.779
TTM45.6485Y41.515+4.133
5Y41.51510Y129.416-87.901
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The EOD is 18.344. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 19.692. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -58.711. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD18.344MRQ19.692-1.348
MRQ19.692TTM-58.711+78.403
TTM-58.711YOY6.852-65.563
TTM-58.7115Y-87.567+28.856
5Y-87.56710Y-388.052+300.485
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Boai NKY Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.88 means the investor is paying ¥1.88 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Boai NKY Pharmaceuticals Ltd:

  • The EOD is 1.752. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.880. Based on the equity, the company is underpriced. +1
  • The TTM is 2.327. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.752MRQ1.880-0.129
MRQ1.880TTM2.327-0.446
TTM2.327YOY2.142+0.185
TTM2.3275Y2.061+0.265
5Y2.06110Y9.295-7.234
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Boai NKY Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6400.253+153%0.084+664%0.354+81%0.243+163%
Book Value Per Share--10.64810.068+6%9.612+11%9.334+14%6.043+76%
Current Ratio--2.8382.876-1%4.182-32%2.109+35%1.027+176%
Debt To Asset Ratio--0.1350.144-6%0.137-2%0.221-39%0.196-31%
Debt To Equity Ratio--0.1550.167-7%0.159-2%0.299-48%0.266-42%
Dividend Per Share--0.0010.127-99%0.006-77%0.054-97%0.045-97%
Eps--0.4420.324+37%0.342+30%0.183+141%0.117+279%
Free Cash Flow Per Share--0.2540.069+271%-0.145+157%-0.005+102%-0.030+112%
Free Cash Flow To Equity Per Share--0.254-0.172+168%-0.931+466%-0.243+195%-0.019+107%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.973--------
Intrinsic Value_10Y_min---6.611--------
Intrinsic Value_1Y_max--0.042--------
Intrinsic Value_1Y_min---0.212--------
Intrinsic Value_3Y_max--0.626--------
Intrinsic Value_3Y_min---1.031--------
Intrinsic Value_5Y_max--1.814--------
Intrinsic Value_5Y_min---2.275--------
Market Cap6016527001.600-7%6458491719.6807551807757.130-14%7105016549.375-9%6085630187.115+6%9898173404.727-35%
Net Profit Margin--0.3340.261+28%0.313+7%0.180+85%0.176+90%
Operating Margin---0.266-100%0.221-100%0.207-100%0.101-100%
Operating Ratio--0.9311.092-15%1.320-29%1.285-28%0.899+3%
Pb Ratio1.752-7%1.8802.327-19%2.142-12%2.061-9%9.295-80%
Pe Ratio10.540-7%11.31445.648-75%20.869-46%41.515-73%129.416-91%
Price Per Share18.650-7%20.02023.335-14%20.625-3%18.426+9%30.469-34%
Price To Free Cash Flow Ratio18.344-7%19.692-58.711+398%6.852+187%-87.567+545%-388.052+2071%
Price To Total Gains Ratio29.087-7%31.224-523.191+1776%1.320+2266%-67.554+316%253.793-88%
Quick Ratio--1.0221.150-11%1.866-45%0.925+10%0.837+22%
Return On Assets--0.0360.027+31%0.030+18%0.016+127%0.016+129%
Return On Equity--0.0410.032+31%0.035+17%0.019+114%0.019+116%
Total Gains Per Share--0.6410.380+69%0.090+611%0.408+57%0.288+122%
Usd Book Value--475405830.698450847604.149+5%458178637.391+4%426200798.118+12%274414563.417+73%
Usd Book Value Change Per Share--0.0890.035+153%0.012+664%0.049+81%0.034+163%
Usd Book Value Per Share--1.4741.393+6%1.330+11%1.292+14%0.836+76%
Usd Dividend Per Share--0.0000.018-99%0.001-77%0.007-97%0.006-97%
Usd Eps--0.0610.045+37%0.047+30%0.025+141%0.016+279%
Usd Free Cash Flow--11348061.3873059394.809+271%-6847134.614+160%-307313.345+103%-1295138.225+111%
Usd Free Cash Flow Per Share--0.0350.009+271%-0.020+157%-0.001+102%-0.004+112%
Usd Free Cash Flow To Equity Per Share--0.035-0.024+168%-0.129+466%-0.034+195%-0.003+107%
Usd Market Cap832687337.021-7%893855254.0041045170193.587-14%983334290.434-9%842251217.897+6%1369907199.214-35%
Usd Price Per Share2.581-7%2.7713.230-14%2.855-3%2.550+9%4.217-34%
Usd Profit--19751434.27014491917.384+36%16282357.790+21%8426910.873+134%5326118.183+271%
Usd Revenue--59168299.48354180432.948+9%51247531.810+15%42360998.031+40%27602299.160+114%
Usd Total Gains Per Share--0.0890.053+69%0.012+611%0.056+57%0.040+122%
 EOD+4 -4MRQTTM+26 -9YOY+26 -95Y+30 -510Y+26 -9

3.2. Fundamental Score

Let's check the fundamental score of Boai NKY Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.540
Price to Book Ratio (EOD)Between0-11.752
Net Profit Margin (MRQ)Greater than00.334
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.022
Current Ratio (MRQ)Greater than12.838
Debt to Asset Ratio (MRQ)Less than10.135
Debt to Equity Ratio (MRQ)Less than10.155
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.036
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Boai NKY Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.332
Ma 20Greater thanMa 5018.988
Ma 50Greater thanMa 10017.363
Ma 100Greater thanMa 20018.084
OpenGreater thanClose18.600
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,970,862
Total Liabilities535,848
Total Stockholder Equity3,459,765
 As reported
Total Liabilities 535,848
Total Stockholder Equity+ 3,459,765
Total Assets = 3,970,862

Assets

Total Assets3,970,862
Total Current Assets1,275,837
Long-term Assets2,695,024
Total Current Assets
Cash And Cash Equivalents 310,257
Short-term Investments 29,416
Net Receivables 430,131
Inventory 282,976
Other Current Assets 32,902
Total Current Assets  (as reported)1,275,837
Total Current Assets  (calculated)1,085,683
+/- 190,155
Long-term Assets
Property Plant Equipment 948,919
Goodwill 341,662
Intangible Assets 147,221
Long-term Assets Other 880,534
Long-term Assets  (as reported)2,695,024
Long-term Assets  (calculated)2,318,336
+/- 376,689

Liabilities & Shareholders' Equity

Total Current Liabilities449,631
Long-term Liabilities86,217
Total Stockholder Equity3,459,765
Total Current Liabilities
Short Long Term Debt 19,951
Accounts payable 250,118
Other Current Liabilities 2,764
Total Current Liabilities  (as reported)449,631
Total Current Liabilities  (calculated)272,833
+/- 176,798
Long-term Liabilities
Long term Debt 45,034
Capital Lease Obligations Min Short Term Debt125
Long-term Liabilities  (as reported)86,217
Long-term Liabilities  (calculated)45,159
+/- 41,058
Total Stockholder Equity
Retained Earnings 975,228
Total Stockholder Equity (as reported)3,459,765
Total Stockholder Equity (calculated)975,228
+/- 2,484,536
Other
Capital Stock322,602
Common Stock Shares Outstanding 322,602
Net Invested Capital 3,524,749
Net Working Capital 826,206
Property Plant and Equipment Gross 948,919



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312008-12-312007-12-31
> Total Assets 
66,664
91,454
110,801
116,312
117,100
355,188
357,812
363,504
370,256
396,017
389,738
396,947
385,953
399,208
409,622
404,754
394,812
401,097
422,643
426,538
432,642
448,411
474,629
485,009
478,935
1,229,158
1,235,974
1,560,209
1,560,776
1,297,962
1,309,901
1,347,628
1,370,077
1,563,496
1,958,640
2,007,792
2,071,299
2,162,321
2,344,189
4,043,872
4,095,437
4,196,717
4,207,439
4,217,521
4,139,859
4,145,478
4,242,799
4,360,085
4,373,191
3,989,888
3,804,327
3,736,013
3,818,965
3,713,523
3,793,407
3,740,385
3,970,862
3,970,8623,740,3853,793,4073,713,5233,818,9653,736,0133,804,3273,989,8884,373,1914,360,0854,242,7994,145,4784,139,8594,217,5214,207,4394,196,7174,095,4374,043,8722,344,1892,162,3212,071,2992,007,7921,958,6401,563,4961,370,0771,347,6281,309,9011,297,9621,560,7761,560,2091,235,9741,229,158478,935485,009474,629448,411432,642426,538422,643401,097394,812404,754409,622399,208385,953396,947389,738396,017370,256363,504357,812355,188117,100116,312110,80191,45466,664
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
642,699
932,178
943,200
1,130,297
1,146,684
1,087,971
944,574
1,090,875
1,181,560
1,281,249
1,255,634
2,190,063
1,757,796
1,658,512
1,703,798
1,433,311
1,341,900
1,200,713
1,275,837
1,275,8371,200,7131,341,9001,433,3111,703,7981,658,5121,757,7962,190,0631,255,6341,281,2491,181,5601,090,875944,5741,087,9711,146,6841,130,297943,200932,178642,69900000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,450
270,220
251,491
285,159
262,706
226,611
172,061
231,640
267,932
372,429
280,614
1,162,129
805,796
445,246
467,788
544,928
487,934
270,968
310,257
310,257270,968487,934544,928467,788445,246805,7961,162,129280,614372,429267,932231,640172,061226,611262,706285,159251,491270,220139,45000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
45,035
66,721
73,203
64,134
201,711
41,417
221,939
229,935
31,995
30,879
32,930
29,416
29,41632,93030,87931,995229,935221,93941,417201,71164,13473,20366,72145,0358,00000000000000000000000000000000000000000000000
       Net Receivables 
12,228
17,955
14,460
14,829
18,662
18,058
19,893
26,085
21,904
26,979
24,014
37,113
41,815
31,932
27,751
32,552
35,199
27,198
35,582
36,650
38,976
43,040
32,797
34,505
38,197
80,513
69,575
88,002
95,244
88,298
84,798
104,022
119,000
127,660
112,122
154,045
191,091
220,160
170,102
271,841
302,674
594,783
605,592
617,112
500,703
540,500
529,940
516,127
537,453
534,052
588,477
664,271
735,679
499,783
515,071
518,053
430,131
430,131518,053515,071499,783735,679664,271588,477534,052537,453516,127529,940540,500500,703617,112605,592594,783302,674271,841170,102220,160191,091154,045112,122127,660119,000104,02284,79888,29895,24488,00269,57580,51338,19734,50532,79743,04038,97636,65035,58227,19835,19932,55227,75131,93241,81537,11324,01426,97921,90426,08519,89318,05818,66214,82914,46017,95512,228
       Other Current Assets 
4,098
8,026
6,138
7,786
2,479
9,831
5,943
10,539
8,186
13,383
6,201
5,934
4,202
17,218
5,133
6,988
6,876
8,278
4,274
10,609
8,838
18,656
4,277
6,023
7,272
21,912
17,252
90,540
27,160
65,799
15,032
56,502
55,677
73,285
39,723
90,013
69,844
68,643
21,896
14,165
18,253
66,595
77,241
58,142
67,475
152,604
96,086
76,863
97,244
61,709
66,053
47,186
88,011
109,640
73,352
90,553
32,902
32,90290,55373,352109,64088,01147,18666,05361,70997,24476,86396,086152,60467,47558,14277,24166,59518,25314,16521,89668,64369,84490,01339,72373,28555,67756,50215,03265,79927,16090,54017,25221,9127,2726,0234,27718,6568,83810,6094,2748,2786,8766,9885,13317,2184,2025,9346,20113,3838,18610,5395,9439,8312,4797,7866,1388,0264,098
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,701,490
3,111,694
3,152,237
3,066,421
3,060,755
3,129,549
3,195,285
3,054,604
3,061,239
3,078,837
3,117,557
1,799,825
2,046,531
2,077,501
2,115,167
2,280,212
2,451,507
2,539,673
2,695,024
2,695,0242,539,6732,451,5072,280,2122,115,1672,077,5012,046,5311,799,8253,117,5573,078,8373,061,2393,054,6043,195,2853,129,5493,060,7553,066,4213,152,2373,111,6941,701,49000000000000000000000000000000000000000
       Property Plant Equipment 
15,632
21,713
31,843
49,544
34,618
39,776
64,293
56,650
87,195
111,018
171,972
168,260
210,235
221,343
257,744
244,456
270,000
255,251
288,767
268,483
277,222
283,803
292,894
297,284
301,082
334,705
338,641
334,665
341,174
346,399
360,222
414,381
420,251
434,290
445,611
467,016
480,525
507,524
506,939
456,859
482,217
569,552
566,381
617,145
653,389
610,955
623,075
634,753
671,516
731,248
782,157
806,579
853,757
844,797
885,777
926,450
948,919
948,919926,450885,777844,797853,757806,579782,157731,248671,516634,753623,075610,955653,389617,145566,381569,552482,217456,859506,939507,524480,525467,016445,611434,290420,251414,381360,222346,399341,174334,665338,641334,705301,082297,284292,894283,803277,222268,483288,767255,251270,000244,456257,744221,343210,235168,260171,972111,01887,19556,65064,29339,77634,61849,54431,84321,71315,632
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
419,355
427,997
427,997
427,997
441,143
441,207
441,207
441,207
442,004
442,126
442,126
442,126
442,126
442,126
2,128,268
2,128,268
2,155,195
2,155,195
2,155,143
2,155,278
2,115,472
2,115,623
2,115,504
2,115,491
341,662
341,662
342,009
342,009
341,662
341,662
341,662
341,662
341,662341,662341,662341,662342,009342,009341,662341,6622,115,4912,115,5042,115,6232,115,4722,155,2782,155,1432,155,1952,155,1952,128,2682,128,268442,126442,126442,126442,126442,126442,004441,207441,207441,207441,143427,997427,997427,997419,3550000000000000000000000000
       Intangible Assets 
3,919
3,834
16,335
40
16,159
16,071
37
16,426
34
18,120
2,005
22,301
1,980
22,055
1,956
21,810
1,933
21,564
2,087
21,464
22,108
23,562
24,011
23,838
23,666
489,106
496,935
496,800
495,363
511,355
512,322
511,866
511,145
510,931
508,469
510,404
522,874
524,322
66,123
54,418
73,897
79,561
77,269
81,555
115,970
126,029
124,608
128,387
126,530
145,693
150,408
148,237
142,127
149,294
147,883
147,603
147,221
147,221147,603147,883149,294142,127148,237150,408145,693126,530128,387124,608126,029115,97081,55577,26979,56173,89754,41866,123524,322522,874510,404508,469510,931511,145511,866512,322511,355495,363496,800496,935489,10623,66623,83824,01123,56222,10821,4642,08721,5641,93321,8101,95622,0551,98022,3012,00518,1203416,4263716,07116,1594016,3353,8343,919
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
87,582
79,354
79,715
52,052
48,748
18,000
691,337
3,304
3,304
3,304
3,304
375,000
565,007
565,000
565,000
731,159
761,121
802,913
880,534
880,534802,913761,121731,159565,000565,000565,007375,0003,3043,3043,3043,304691,33718,00048,74852,05279,71579,35487,58200000000000000000000000000000000000000
> Total Liabilities 
48,842
47,523
48,661
48,260
42,775
27,084
24,599
24,722
30,205
49,846
38,805
40,469
30,499
39,286
45,815
36,037
26,583
27,866
45,583
43,984
48,458
54,904
74,382
71,684
64,322
83,544
73,109
376,876
372,318
87,534
83,322
96,953
108,976
278,240
656,224
679,614
830,293
896,138
1,040,019
1,052,957
1,059,643
1,144,104
1,142,035
1,121,775
1,025,364
1,069,242
1,101,643
1,195,006
1,177,008
589,763
494,084
530,989
492,200
596,287
557,070
498,695
535,848
535,848498,695557,070596,287492,200530,989494,084589,7631,177,0081,195,0061,101,6431,069,2421,025,3641,121,7751,142,0351,144,1041,059,6431,052,9571,040,019896,138830,293679,614656,224278,240108,97696,95383,32287,534372,318376,87673,10983,54464,32271,68474,38254,90448,45843,98445,58327,86626,58336,03745,81539,28630,49940,46938,80549,84630,20524,72224,59927,08442,77548,26048,66147,52348,842
   > Total Current Liabilities 
48,842
47,523
45,632
45,246
39,776
24,100
21,630
21,768
27,267
45,623
34,673
36,353
26,397
35,200
39,905
30,566
21,147
22,835
40,181
38,282
42,758
47,965
67,442
64,004
56,702
75,716
57,797
292,013
287,506
61,795
57,686
81,496
93,318
263,136
641,359
665,143
815,963
863,321
981,435
895,835
890,531
976,686
973,769
957,110
866,366
1,001,228
1,032,269
1,117,850
1,107,430
501,649
414,371
435,036
395,665
502,029
465,537
409,851
449,631
449,631409,851465,537502,029395,665435,036414,371501,6491,107,4301,117,8501,032,2691,001,228866,366957,110973,769976,686890,531895,835981,435863,321815,963665,143641,359263,13693,31881,49657,68661,795287,506292,01357,79775,71656,70264,00467,44247,96542,75838,28240,18122,83521,14730,56639,90535,20026,39736,35334,67345,62327,26721,76821,63024,10039,77645,24645,63247,52348,842
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
659,298
710,393
689,688
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000689,688710,393659,29800000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
659,298
710,393
689,688
801,142
812,275
759,808
683,397
654,986
669,749
686,176
685,515
39,429
35,743
31,008
16,676
16,673
16,426
18,918
19,951
19,95118,91816,42616,67316,67631,00835,74339,429685,515686,176669,749654,986683,397759,808812,275801,142689,688710,393659,29800000000000000000000000000000000000000
       Accounts payable 
7,179
10,763
7,108
10,837
2,583
3,320
9,196
9,441
11,533
15,917
20,989
22,231
15,643
25,956
30,449
23,775
16,147
17,671
34,384
30,242
33,681
36,375
34,157
37,951
33,140
26,604
20,568
32,089
36,666
26,894
29,271
56,143
64,471
62,732
70,710
55,869
56,740
113,403
73,410
68,193
114,694
37,364
52,579
72,945
109,898
146,037
196,124
213,622
187,759
188,278
169,501
180,563
109,590
211,215
211,941
180,929
250,118
250,118180,929211,941211,215109,590180,563169,501188,278187,759213,622196,124146,037109,89872,94552,57937,364114,69468,19373,410113,40356,74055,86970,71062,73264,47156,14329,27126,89436,66632,08920,56826,60433,14037,95134,15736,37533,68130,24234,38417,67116,14723,77530,44925,95615,64322,23120,98915,91711,5339,4419,1963,3202,58310,8377,10810,7637,179
       Other Current Liabilities 
31,663
24,760
24,774
9,659
7,443
6,780
8,434
8,327
11,734
9,706
8,684
9,122
5,754
4,244
4,456
6,791
5,000
5,164
5,797
8,041
9,077
6,589
8,284
11,053
8,562
34,112
37,229
34,924
25,840
20,901
28,416
25,353
28,846
25,405
25,649
27,274
58,471
167,918
0
0
79,827
112,281
103,002
117,320
65,943
100,917
159,261
178,900
195,449
249,721
203,713
195,675
252,041
253,643
221,835
181,963
2,764
2,764181,963221,835253,643252,041195,675203,713249,721195,449178,900159,261100,91765,943117,320103,002112,28179,82700167,91858,47127,27425,64925,40528,84625,35328,41620,90125,84034,92437,22934,1128,56211,0538,2846,5899,0778,0415,7975,1645,0006,7914,4564,2445,7549,1228,6849,70611,7348,3278,4346,7807,4439,65924,77424,76031,663
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,584
157,122
169,112
167,418
168,266
164,665
158,998
68,014
69,374
77,156
69,578
88,114
79,713
95,953
96,535
94,258
91,533
88,844
86,217
86,21788,84491,53394,25896,53595,95379,71388,11469,57877,15669,37468,014158,998164,665168,266167,418169,112157,12258,58400000000000000000000000000000000000000
       Other Liabilities 
0
0
3,029
3,014
2,999
2,984
2,969
2,954
2,938
4,223
4,132
4,116
4,102
4,086
5,910
5,471
5,436
5,031
5,402
5,702
5,701
6,939
6,941
7,680
7,621
7,828
7,782
7,333
7,522
8,381
8,682
8,523
8,818
8,408
8,290
8,015
7,994
8,404
13,050
12,699
25,817
31,890
31,410
34,579
30,917
32,429
35,596
35,165
33,412
33,884
27,541
43,526
45,708
44,540
43,362
42,239
0
042,23943,36244,54045,70843,52627,54133,88433,41235,16535,59632,42930,91734,57931,41031,89025,81712,69913,0508,4047,9948,0158,2908,4088,8188,5238,6828,3817,5227,3337,7827,8287,6217,6806,9416,9395,7015,7025,4025,0315,4365,4715,9104,0864,1024,1164,1324,2232,9382,9542,9692,9842,9993,0143,02900
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,080
12,296
15,343
17,805
24,361
18,370
18,100
19,900
20,021
21,487
21,040
39,319
46,743
45,865
41,060
41,237
41,657
43,558
0
043,55841,65741,23741,06045,86546,74339,31921,04021,48720,02119,90018,10018,37024,36117,80515,34312,29611,08000000000000000000000000000000000000000
> Total Stockholder Equity
17,822
43,931
62,139
68,052
74,326
328,104
333,213
338,782
340,050
346,171
350,934
356,478
355,455
359,922
363,807
368,717
368,228
373,231
377,060
382,554
384,183
393,507
400,247
413,325
414,612
1,145,614
1,162,865
1,183,332
1,188,458
1,209,849
1,225,846
1,249,957
1,260,278
1,284,326
1,301,860
1,326,147
1,237,758
1,264,585
1,303,661
2,984,675
3,028,740
3,047,921
3,062,327
3,092,864
3,113,026
3,078,760
3,145,006
3,170,442
3,203,122
3,411,720
3,323,078
3,217,421
3,336,857
3,135,809
3,256,726
3,261,312
3,459,765
3,459,7653,261,3123,256,7263,135,8093,336,8573,217,4213,323,0783,411,7203,203,1223,170,4423,145,0063,078,7603,113,0263,092,8643,062,3273,047,9213,028,7402,984,6751,303,6611,264,5851,237,7581,326,1471,301,8601,284,3261,260,2781,249,9571,225,8461,209,8491,188,4581,183,3321,162,8651,145,614414,612413,325400,247393,507384,183382,554377,060373,231368,228368,717363,807359,922355,455356,478350,934346,171340,050338,782333,213328,10474,32668,05262,13943,93117,822
   Common Stock
8,000
27,000
27,000
27,000
27,000
36,000
36,000
36,000
72,000
72,000
72,000
72,000
115,200
115,200
115,200
115,200
115,200
115,200
115,200
115,200
115,200
115,200
115,200
115,200
115,200
170,482
170,482
170,482
170,482
170,482
170,482
170,482
170,482
170,482
169,732
169,732
169,732
220,652
217,936
323,069
323,069
323,069
323,069
323,069
323,069
323,069
323,069
343,619
343,619
343,619
343,619
345,119
345,119
323,905
323,905
323,905
0
0323,905323,905323,905345,119345,119343,619343,619343,619343,619323,069323,069323,069323,069323,069323,069323,069323,069217,936220,652169,732169,732169,732170,482170,482170,482170,482170,482170,482170,482170,482170,482115,200115,200115,200115,200115,200115,200115,200115,200115,200115,200115,200115,200115,20072,00072,00072,00072,00036,00036,00036,00027,00027,00027,00027,0008,000
   Retained Earnings 
7,807
9,117
16,386
22,299
28,572
34,304
37,198
42,767
44,035
50,156
52,404
57,948
49,725
54,192
56,064
60,974
60,485
65,488
67,257
83,335
84,970
94,321
101,047
114,086
115,399
128,861
146,513
166,976
172,102
193,476
209,505
233,608
243,857
267,876
285,430
309,756
321,959
348,643
350,985
360,393
404,286
459,005
471,012
503,152
529,386
497,119
559,554
574,123
590,730
783,777
816,382
752,635
884,068
813,700
933,680
913,954
975,228
975,228913,954933,680813,700884,068752,635816,382783,777590,730574,123559,554497,119529,386503,152471,012459,005404,286360,393350,985348,643321,959309,756285,430267,876243,857233,608209,505193,476172,102166,976146,513128,861115,399114,086101,04794,32184,97083,33567,25765,48860,48560,97456,06454,19249,72557,94852,40450,15644,03542,76737,19834,30428,57222,29916,3869,1177,807
   Capital Surplus 000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000-100,498-100,498000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
828
1,350
1,521
3,371
5,770
4,167
-1,904
-3,903
-92
-4,239
-3,414
-3,223
-2,157
7,986
9,973
6,391
6,119
78,094
0
078,0946,1196,3919,9737,986-2,157-3,223-3,414-4,239-92-3,903-1,9044,1675,7703,3711,5211,35082800000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,565,908
Cost of Revenue-713,755
Gross Profit852,153852,153
 
Operating Income (+$)
Gross Profit852,153
Operating Expense-979,487
Operating Income586,421-127,334
 
Operating Expense (+$)
Research Development61,104
Selling General Administrative110,076
Selling And Marketing Expenses-
Operating Expense979,487171,180
 
Net Interest Income (+$)
Interest Income31,773
Interest Expense-3,072
Other Finance Cost-27,512
Net Interest Income1,189
 
Pretax Income (+$)
Operating Income586,421
Net Interest Income1,189
Other Non-Operating Income Expenses-
Income Before Tax (EBT)553,837586,421
EBIT - interestExpense = -3,072
418,842
421,914
Interest Expense3,072
Earnings Before Interest and Taxes (EBIT)-556,910
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax553,837
Tax Provision-145,031
Net Income From Continuing Ops408,807408,807
Net Income418,842
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--1,189
 

Technical Analysis of Boai NKY Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Boai NKY Pharmaceuticals Ltd. The general trend of Boai NKY Pharmaceuticals Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Boai NKY Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Boai NKY Pharmaceuticals Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 19.73 < 20.50 < 20.53.

The bearish price targets are: 18.55 > 17.44 > 16.80.

Tweet this
Boai NKY Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Boai NKY Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Boai NKY Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Boai NKY Pharmaceuticals Ltd. The current macd is 0.38077589.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Boai NKY Pharmaceuticals Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Boai NKY Pharmaceuticals Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Boai NKY Pharmaceuticals Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Boai NKY Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBoai NKY Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Boai NKY Pharmaceuticals Ltd. The current adx is 24.98.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Boai NKY Pharmaceuticals Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Boai NKY Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Boai NKY Pharmaceuticals Ltd. The current sar is 20.03.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Boai NKY Pharmaceuticals Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Boai NKY Pharmaceuticals Ltd. The current rsi is 52.33. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Boai NKY Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartBoai NKY Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Boai NKY Pharmaceuticals Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Boai NKY Pharmaceuticals Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Boai NKY Pharmaceuticals Ltd Daily Stochastic Oscillator ChartBoai NKY Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Boai NKY Pharmaceuticals Ltd. The current cci is -62.52010724.

Boai NKY Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartBoai NKY Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Boai NKY Pharmaceuticals Ltd. The current cmo is -3.05806756.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Boai NKY Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartBoai NKY Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Boai NKY Pharmaceuticals Ltd. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Boai NKY Pharmaceuticals Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Boai NKY Pharmaceuticals Ltd Daily Williams %R ChartBoai NKY Pharmaceuticals Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Boai NKY Pharmaceuticals Ltd.

Boai NKY Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Boai NKY Pharmaceuticals Ltd. The current atr is 0.72232257.

Boai NKY Pharmaceuticals Ltd Daily Average True Range (ATR) ChartBoai NKY Pharmaceuticals Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Boai NKY Pharmaceuticals Ltd. The current obv is 40,501,950.

Boai NKY Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartBoai NKY Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Boai NKY Pharmaceuticals Ltd. The current mfi is 43.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Boai NKY Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartBoai NKY Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Boai NKY Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Boai NKY Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Boai NKY Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.332
Ma 20Greater thanMa 5018.988
Ma 50Greater thanMa 10017.363
Ma 100Greater thanMa 20018.084
OpenGreater thanClose18.600
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Boai NKY Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Boai NKY Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Boai NKY Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Boai NKY Pharmaceuticals Ltd

I send you an email if I find something interesting about Boai NKY Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Boai NKY Pharmaceuticals Ltd.

Receive notifications about Boai NKY Pharmaceuticals Ltd in your mailbox!